We did not see upregulation of reported tumour-suppressor genes, such as CDKN2A, CDKN2B and PML, and factors for neuronal differentiation, such as SMARCC1 and DLX2, in our microarray analysis. The gene discussed is SMARCC1; the disease is neoplasm.